Please enable Javascript to get a taste of that HopiumĀ šŸ‘¼

Alexion Pharmaceuticals, Inc

Financials

We've grouped the latest 4 financial reports for ALXN. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2017201820192020
Total Revenue3453000000404400000049319000005964000000
Cost of Revenue2274100000187140000019826000004403100000
Gross Margin1178900000375690000045966000005516400000
Research & Development8784000007304000008860000001002900000
Selling, General and Administrative----
Other Operating Expense----
Total Operating Expense----
Operating Income6274000002696000002120400000632300000
Interest Income-79900000-3290000022500000-
Interest Expense984000009820000077800000104700000
Net Interest Incomee-98400000-98200000-77800000-104700000
Other Income Expense----
Non-recurring Items----
Other Non-operating Income300000550000035900000-3300000
Income before Provision for income taxes5478000002422000002178800000569000000
Tax Provision104500000164600000-225500000-34400000
Net Income443300000776000002404300000603400000
Effect of accounting charges----
Minority Interest----
Provision for income taxes----
Non-recurring items----
Other Items----
Discontinued Operations----
Preferred Stock Dividends----
EBIT6462000003404000002256600000673700000
Balance Sheet2017201820192020
Assets
Cash, Cash Equivalents & Short-term investments1474100000156380000027495000002999400000
Cash & Cash Equivalents----
Other Short-term Investments8897000001983000006400000034900000
Receivables----
Inventory460400000472500000627600000862300000
Other Current Assets292900000426400000456100000648600000
Total Current Assets2953900000338500000050764000005833000000
PPE1325400000147150000011633000001238800000
Non-current Marketable Securities12500000---
Other Non-current assets312200000294900000429000000506200000
total non-current assets1062940000010546900000997430000012375500000
Goodwill5037400000503740000050374000005100100000
Other Intangible Assets8991800000867870000083817000008102500000
deferred long-term asset charges----
Total Assets13583300000139319000001754460000018103000000
Liabilities
Accounts Payable----
Current Debt167400000343800000126700000142400000
Other Current Liabilties7490000034400000100900000164100000
Total Current Liabilities952500000117400000011943000001624700000
Long Term Debt2906300000309170000024987000002644700000
Non-Current Deferred Liabilties----
Negative Goodwill----
Other Non-Current Liabilities140200000155600000265600000298800000
total non-current liabilities2880100000267490000026683000004595000000
Total capital lease obligations3429000003610000007290000067300000
Total Liabilities4690200000476660000062728000006451800000
Shareholder's Equity
Common Stock----
Share premium----
Preferred Stock----
Retained Earnings----
Additional Paid-in Capital----
Gains/Losses not affecting retained earnings----
Treasury Stock1604900000168990000021059000002620300000
Total Shareholders' Equity889310000091653000001127180000011651200000
Total Liabilities and Shareholders' Equity----
Cash Flow2017201820192020
Cash from Operating Activities
Operating Activities111560000042600000020849000003002900000
Other Operating Activities----
Change(increase) in Operating Activities----
Net Income443300000776000002404300000603400000
Depreciation----
Change in Liabilities----
Change in Inventory8820000035200000160200000-95000000
Change(increase) in Account Receivables----
Change(increase) in Receivables55200000208800000319200000139400000
Cash from Investing Activities
Investment Activities-9183000004705000009700000-2099500000
Other Investment Activities----
Investments----
Capital Expenditures357300000213000000170700000106700000
Cash from Financing Activities
Financing Activities-596600000-102400000-739100000-611900000
Other Financing Activities----
Stock Sale and Purchase----
Dividends----
Net Borrowings----
Change(increase) in Cash----
Change(increase) in Cash and Cash Equivalents-3816000007829000001356300000311000000
Change(increase) in Net Income----
Change in Exchange Rate17700000-1120000080000019500000
Data source(s): Alpha Vantage